Article
Update of hematopoietic cell transplantation for sickle cell disease
12 Mar 2015
Abstract excerpt
PURPOSE OF REVIEW: Hematopoietic cell transplantation (HCT) is a curative therapy for sickle cell disease (SCD) that is utilized very rarely because of limited allogeneic donor availability, limited healthcare resources needed to expand the treatment to regions in the world where most affected individuals reside, and by a view among SCD experts that HCT lacks the evidential rigor with short and long-term toxicity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
